Maze Therapeutics (MAZE) Enterprise Value (2024 - 2026)
Maze Therapeutics (MAZE) reported Enterprise Value of -$352.4 million for Q1 2026, down 19.71% on a YoY basis from -$438.9 million in Q1 2025, and down 3.06% sequentially from -$341.9 million in Q4 2025.
Maze Therapeutics (MAZE) Enterprise Value (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Enterprise Value data on file, last reported at -$352.4 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 19.71% year-over-year to -$352.4 million; the trailing twelve-month figure through Mar 2026 stood at -$352.4 million (down 19.71% YoY), and the FY2025 full-year result was -$341.9 million, down 73.73% from the prior year.
- Enterprise Value slipped to -$352.4 million in Q1 2026, from -$341.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$30.0 million in Q1 2024 to a low of -$383.9 million in Q3 2025.
- A 3-year average of -$243.2 million and a median of -$264.5 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 880.49% in 2025 and retreated 19.71% in 2026, its largest moves.
- Tracing MAZE's Enterprise Value over 3 years: stood at -$196.8 million in 2024, then sank by 73.73% to -$341.9 million in 2025, then dropped by 3.06% to -$352.4 million in 2026.
- Business Quant data shows MAZE's Enterprise Value at -$352.4 million in Q1 2026, -$341.9 million in Q4 2025, and -$383.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | -352.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -352.38 Mn |
| Dec 31, 2025 | -341.92 Mn |
| Sep 30, 2025 | -383.94 Mn |
| Jun 30, 2025 | -264.54 Mn |
| Mar 31, 2025 | -294.37 Mn |
| Dec 31, 2024 | -196.81 Mn |
| Sep 30, 2024 | -149.61 Mn |
| Jun 30, 2024 | -175.07 Mn |
| Mar 31, 2024 | -30.02 Mn |